Newsfeeds - Spark Newswire

5 minute read

60 Biggest Movers From Yesterday

Today, 9:46 AM

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of Painshield relief for over-the-counter use and plans for future product launch.

ABSI

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 9:46 AM

ABSI

3 minute read

38 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 9:46 AM

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for over-the-counter use and plans for future product launch.

ABSI

19 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 16, 2021

By Benzinga Insights

Today, 9:46 AM

Upgrades

ABSI

1 minute read

Stifel Initiates Coverage On Absci with Hold Rating, Announces Price Target of $28

By Benzinga Newsdesk

Today, 9:46 AM

Stifel analyst Daniel Arias initiates coverage on Absci (NASDAQ:ABSI) with a Hold rating and announces Price Target of $28.

ABSI

1 minute read

B of A Securities Initiates Coverage On Absci with Neutral Rating, Announces Price Target of $26

By Benzinga Newsdesk

Today, 9:46 AM

B of A Securities analyst Michael Ryskin initiates coverage on Absci (NASDAQ:ABSI) with a Neutral rating and announces Price Target of $26.

ABSI

1 minute read

Cowen & Co. Initiates Coverage On Absci with Market Perform Rating

By Benzinga Newsdesk

Today, 9:46 AM

Cowen & Co. analyst Doug Schenkel initiates coverage on Absci (NASDAQ:ABSI) with a Market Perform rating.

ABSI

1 minute read

Credit Suisse Initiates Coverage On Absci with Outperform Rating, Announces Price Target of $40

By Benzinga Newsdesk

Today, 9:46 AM

Credit Suisse analyst Tiago Fauth initiates coverage on Absci (NASDAQ:ABSI) with a Outperform rating and announces Price Target of $40.

ABSI

3 minute read

The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow

By Shanthi Rexaline

Today, 9:46 AM

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among those reporting during the week.

ABSI

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 9:46 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI